Showing 81 - 90 of 980
Millions at risk from known diseases as focus shifts to COVID-19
AFP, Published on 07/05/2020
» PARIS - As COVID-19 deaths climb ever higher in Europe and the United States, millions of lives are at risk in developing nations where lockdowns and overwhelmed medical systems are disrupting vital testing, vaccination and treatment for other killer diseases.
The Wuhan lab at the heart of the US-China virus spat
AFP, Published on 06/05/2020
» BEIJING: The Chinese laboratory accused by top American officials of being the source of the coronavirus pandemic conducts research on the world's most dangerous diseases.
Spain eases strict lockdown as US approves virus drug
AFP, Published on 03/05/2020
» MADRID - Spaniards took to the streets to jog, cycle and rollerskate for the first time following 48 days of confinement on Saturday as some European nations cautiously eased virus lockdowns while Russia reported a sudden surge in its infections.
Spain eases strict lockdown as US approves virus drug
AFP, Published on 02/05/2020
» MADRID - Spaniards took to the streets to jog, cycle and rollerskate for the first time after 48 days of confinement on Saturday as some European nations cautiously eased virus lockdowns and Russia faced a large spike in new infections.
Remdesivir: The COVID-19 drug helping patients recover faster
AFP, Published on 01/05/2020
» WASHINGTON - Remdesivir has been shown to speed up recovery times for patients with COVID-19 in a major US-led trial, becoming the first drug with proven benefit against the disease.
Virus hammers plunging world economy but South Korea turns corner
AFP, Published on 30/04/2020
» BRUSSELS - A day without a new coronavirus case in South Korea and a potential breakthrough in the hunt for a better treatment spurred optimism on Thursday, but catastrophic European figures underlined how much damage the epidemic has already done the global economy.
US says Remdesivir shows 'clear-cut' effect on coronavirus
AFP, Published on 30/04/2020
» WASHINGTON: Remdesivir has a "clear-cut" effect in helping Covid-19 patients recover, a top US scientist who oversaw a large clinical trial into the highly-anticipated antiviral said Wednesday, hailing it as proof that a drug can block the coronavirus.
How to develop a vaccine for all
Oped, Published on 30/04/2020
» In the early weeks of 2020, it started to dawn on people that Covid-19 could be the long-dreaded but expected "Disease X" -- a global pandemic caused by an unknown virus. Three months later, the majority of the world's population is in lockdown, and it is clear that we are only as healthy as our neighbours -- locally, nationally, and internationally.
Life on the Covid-19 frontline
News, Published on 27/04/2020
» As people stay home to do their bit to combat the Covid-19 pandemic, healthcare workers are vigilant on the frontline, providing treatment and preventing the disease from spreading further.
Lockdown peril haunts abusive homes
Oped, Boonwara Sumano, Published on 22/04/2020
» Some of the key policies to curtail the widespread transmission of the coronavirus or Covid-19 are city-lockdowns and self-isolation. The Thai government has been urging people to stay at home and shut down places for mass gatherings, including schools and childcare centres, since March 22.